Monday, 9 May 2016

Overview of the Cancer and Immune Signalling Laboratory, 12 May

The second CiiiD / CID combined seminar will be held Tuesday 12th May with Prof Brendan Jenkins as speaker.

The seminar will be held 12-1pm in the TRF Seminar Room 1.  Lunch will be available from 11.45am.

Prof Brendan Jenkins
NHMRC Senior Research Fellow
Centre for Innate Immunity and Infectious Diseases

Since establishing his research group at Hudson in 2006, Professor Brendan Jenkins has investigated the roles of IL-6 family cytokines and pattern recognition receptors in stomach and lung cancer, as well as emphysema/chronic obstructive pulmonary disease (COPD) and other chronic inflammatory conditions (peritonitis, arthritis). Collectively, his research programs incorporate long-standing collaborations with basic scientific researchers, industry, and clinicians both nationwide and overseas. Amongst his scientific achievements are publications in the highest-ranking science and medical research journals, including Cancer Cell, Nature Medicine, Nature, Immunity, Journal of Clinical Investigation, Journal of Experimental Medicine, Cancer Research, Oncogene, Proceedings of the National Academy of Sciences USA, and Journal of Immunology, among others.

Professor Jenkins is a NHMRC Senior Research Fellow has held numerous other fellowships, including a prestigious Sylvia and Charles Viertel Senior Medical Research Fellowship. In recognition of his research achievements, he has also received many national and international awards, including the Australian Institute for Policy and Science Tall Poppy Award. In addition he is a holder of multiple project grants funded from within Australia (NHMRC, Cancer Council) and overseas (Association for International Cancer Research), and is a regular invited speaker at local and international scientific meetings.

No comments:

Post a Comment